Allulose Gains Attention in Sugar Reduction Efforts
Allulose, known for its properties of reducing sugar content in food products while not affecting blood glucose levels, is becoming a focal ingredient for manufacturers aiming to meet clean-label demands. Unlike regular sugar, allulose behaves similarly in texture and browning properties in baking and confectionery but does not cause insulin release, making it a valuable component in sweetener systems.
Swiss chocolate maker Lindt & Sprüngli, collaborating with ingredients manufacturer Savanna Ingredients, has filed for a patent involving an allulose-containing chocolate, highlighting the industry's interest in expanding beyond mere sweetness to retain sensory qualities in sugar-reduced products.
Composition and Metabolism
Allulose, also known as D-Allulose or D-psicose, is only 70% as sweet as sucrose and is not metabolized in a way that provides caloric energy. It is excreted in urine without affecting blood glucose or insulin levels.
Market Approval and Supply
While approved in countries including the US, China, Japan, and others, allulose remains unauthorized in the European Union pending regulatory processes. Suppliers such as Samyang and Daesang in South Korea, along with several Chinese companies like Shandong Sanyuan Bio, lead the production and distribution of allulose globally.
Potential Drawbacks
Despite its benefits, allulose in high quantities may cause digestive issues such as bloating and diarrhea. Additionally, a legal dispute in the US challenges the labeling practices for products containing allulose under current FDA guidelines.
As the demand for sugar alternatives rises, the interest in allulose is likely to grow, provided manufacturers can navigate regulatory landscapes and potential health impacts.
